Identification of Urine Biomarkers to Improve Eligibility for Prostate Biopsy and Detect High-Grade Prostate Cancer

SIMPLE SUMMARY: The screening of prostate cancer (PCa), based on the serum prostate specific antigen (PSA), is characterized by a high number of false positives, leading to overdiagnosis of healthy men and overtreatment of indolent PCa. This clinical problem severely affects the quality of life of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Alijaj, Nagjie, Pavlovic, Blaz, Martel, Paul, Rakauskas, Arnas, Cesson, Valérie, Saba, Karim, Hermanns, Thomas, Oechslin, Pascal, Veit, Markus, Provenzano, Maurizio, Rüschoff, Jan H., Brada, Muriel D., Rupp, Niels J., Poyet, Cédric, Derré, Laurent, Valerio, Massimo, Banzola, Irina, Eberli, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909910/
https://www.ncbi.nlm.nih.gov/pubmed/35267445
http://dx.doi.org/10.3390/cancers14051135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909910/
https://www.ncbi.nlm.nih.gov/pubmed/35267445
http://dx.doi.org/10.3390/cancers14051135

Ejemplares similares